Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion

J Virol. 2004 Jul;78(14):7360-8. doi: 10.1128/JVI.78.14.7360-7368.2004.

Abstract

GM3, a major ganglioside of T lymphocytes, promotes human immunodeficiency virus type 1 (HIV-1) entry via interactions with HIV-1 receptors and the viral envelope glycoprotein (Env). Increased GM3 levels in T lymphocytes and the appearance of anti-GM3 antibodies in AIDS patients have been reported earlier. In this study, we investigated the effect of GM3 regulation on HIV-1 entry by utilizing a mouse cell line (B16F10), which expresses exceptionally high levels of GM3. Strikingly, B16 cells bearing CD4, CXCR4, and/or CCR5 were highly resistant to CD4-dependent HIV-1 Env-mediated membrane fusion. In contrast, these targets supported membrane fusion mediated by CD4-requiring HIV-2, SIV, and CD4-independent HIV-1 Envs. Coreceptor function was not impaired by GM3 overexpression as indicated by Ca(2+) fluxes mediated by the CXCR4 ligand SDF-1alpha and the CCR5 ligand MIP-1beta. Reduction in GM3 levels of B16 target cells resulted in a significant recovery of CD4-dependent HIV-1 Env-mediated fusion. We propose that GM3 in the plasma membrane blocks HIV-1 Env-mediated fusion by interfering with the lateral association of HIV-1 receptors. Our findings offer a novel mechanism of interplay between membrane lipids and receptors by which host cells may escape viral infections.

MeSH terms

  • Animals
  • CD4 Antigens / metabolism
  • Cell Line, Tumor
  • G(M3) Ganglioside / metabolism*
  • G(M3) Ganglioside / pharmacology
  • Gene Products, env / metabolism
  • HIV-1 / pathogenicity*
  • HIV-2 / pathogenicity
  • HeLa Cells
  • Humans
  • Membrane Fusion / drug effects*
  • Mice
  • NIH 3T3 Cells
  • Receptors, HIV / chemistry
  • Receptors, HIV / metabolism*
  • Simian Immunodeficiency Virus / pathogenicity

Substances

  • CD4 Antigens
  • G(M3) Ganglioside
  • Gene Products, env
  • Receptors, HIV